Cancer Investigation
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.2 | Q3 | 31.8% | 0.495 | Q3 | 60.5% |
| 2024 | 1.9 | Q3 | 26.1% | 0.505 | Q3 | 62.5% |
| 2023 | 1.8 | Q3 | 25.8% | 0.604 | Q2 | 71.2% |
| 2022 | 2.4 | Q4 | 31.1% | 0.598 | Q2 | 71.9% |
| 2021 | 2.4 | Q4 | 35.3% | 0.568 | Q2 | 71.1% |
| 2020 | — | — | 0.688 | Q2 | 75.7% | |
| 2019 | — | — | 0.984 | Q1 | 85.3% | |
| 2018 | — | — | 0.833 | Q2 | 79.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1532-4192
ISSN
0735-7907
country
UScoverage
1983-2026